Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis.
about
Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritisHodgkin lymphoma and immunodeficiency in persons with HIV/AIDSLymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disordersLymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processesMethotrexate-related lymphomatoid granulomatosis: a case report of spontaneous regression of large tumours in multiple organs after cessation of methotrexate therapy in rheumatoid arthritisSurvival and drug discontinuation analyses in a large cohort of methotrexate treated rheumatoid arthritis patients.Rheumatological manifestations of haematological diseases.Primary juxtaarticular soft tissue lymphoma arising in the vicinity of inflamed joints in patients with rheumatoid arthritis.Differential impact of ageing on cellular and humoral immunity to a persistent murine gamma-herpesvirusLymphoma in patients treated with anti-TNF: results of the 3-year prospective French RATIO registry.Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel disease.Nodal involvement by marginal zone B-cell lymphoma harboring t(14;22)(q32;q11) involving immunoglobulin heavy chain and light chain lambda as the sole karyotypically recognizable abnormality in a patient with systemic lupus erythematosus.Combination therapy: the risks of infection and tumor induction.EBV-associated lymphomas in adultsEpstein-Barr virus-associated lymphomas.Effects of a biologic agent in a patient with rheumatoid arthritis after treatment for methotrexate-associated B-cell lymphoma: a case report.Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is lowStudy of eight cases of cancer in 426 rheumatoid arthritis patients treated with methotrexate.Using haplotype analysis to elucidate significant associations between genes and Hodgkin lymphomaImmunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature.Complete Remission of Methotrexate-Related Epstein-Barr-Virus-Associated Hodgkin-Like Lymphoma following Withdrawal of MTX Coupled with Clarithromycin Administration.Advanced therapeutic and prophylactic strategies for Epstein-Barr virus infection in immunocompromised patients.Lymphoma risk in inflammatory bowel disease: is it the disease or its treatment?Methotrexate in dermatology.Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell.Epstein-Barr-Virus-Infected CD15 (Lewis X)-Positive Hodgkin-Lymphoma-Like B Cells in Patients with Rheumatoid Arthritis.Classical Hodgkin's lymphoma arising in different host's conditions: pathobiology parameters, therapeutic options, and outcome.The use of methotrexate in dermatology: a review.Lymphoma in inflammatory bowel disease and treatment decisions.Does a personal or family history of malignancy preclude the use of immunomodulators and biologics in IBD.Treatment of severe non-infectious uveitis in high-risk conditions (Part I): pregnancy and malignancies, management and safety issues.Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: A review of the literature and current perspective.Methotrexate-associated primary hepatic malignant lymphoma following hepatectomy: A case report.Primary central nervous system malignant lymphoma in a patient with rheumatoid arthritis receiving low-dose methotrexate treatment.Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression.Reversible methotrexate-associated lymphoma of the liver in rheumatoid arthritis: a unique case of primary hepatic lymphoma.Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.Early development of Hodgkin's lymphoma in association with the use of methotrexate for the treatment of dermatomyositis.Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.
P2860
Q24675306-96341F9F-DD9E-49DD-B3E1-971DF7F7463BQ24685909-2C33ED36-0F0A-4183-B1F0-9724EE0319D0Q26776151-982AAA69-A21F-410B-BDB1-0D58AC729954Q28271456-80F02CE9-492F-42F0-9ABF-865E29BB3B12Q28299150-D1C25292-CE3B-44E3-B06D-7241A86A9FE6Q33578306-50745414-DE21-4A46-A0FF-D3983B181D7BQ33578386-E402F764-1120-47A5-8478-5415EA0B3328Q33601888-CE4B7B7B-6495-4121-B9BB-222E59C91BEDQ33745898-4BAAEC05-EAAF-4EA8-820A-CB921EBFA172Q34077378-B60A251D-D7A1-43FD-BD96-56652FB423B5Q34078707-80F85140-BAAA-4F2C-812E-2C49FF93BD55Q34121629-BB9E9FC2-8797-4180-A0BC-F75A7F439966Q34309757-14D4359B-9E1F-4A1B-AFF2-A7C0987FFE80Q34636601-433E6768-FCBE-476D-8211-9D13DCFD4B8BQ34651670-454BCE0D-4234-4905-88C2-C13E9B1202DFQ35144770-EB649F0B-1D58-45F0-B692-12224CC78C06Q35361609-F9F78F7B-2360-4385-B02C-708812A32F67Q35547060-02BDFCF0-B241-4D42-AD76-3B9E1B8102C8Q36253844-CD50A504-2B13-40A3-9AFD-F087D7AF724DQ36371451-C6412D88-E824-4B11-990C-9CCFCEAF872FQ36505005-69D4F61F-3FF0-4E08-8492-217D77FB4F12Q36839720-9C30E25D-EEBD-42B1-8722-0A45930A330CQ36864836-CCD02BA9-5E52-4C28-B5D0-AA7E6F9540ADQ36986025-0A0C5415-47BB-46E3-9E29-AD446791D86FQ37004635-5FE3873F-5839-428F-ACA2-43C003AE27BDQ37350444-3191C1ED-1935-4F68-ACDB-BD9689AFC96DQ37832198-1174AA35-6B8B-4435-BD3F-293739D49B12Q37981730-AE2044F6-4CEA-4DC9-AA42-B642FA132CDBQ38024070-73385222-9E82-4A29-9AAD-E7FEA67C5F7DQ38253832-D238411A-96FD-4318-B648-F91FDAD50BB9Q38464355-5EE0AEC4-3678-4A88-B1DD-F5E66CFA6ED2Q38652100-D2D7554E-943E-4373-8789-EEC203EF2FC1Q39026790-B8B68CFC-0A14-4F9C-BB77-158EF3B2AF01Q39413196-117EB335-35F0-4455-BD82-5285BCDBC1C7Q40055511-C051D368-D165-4551-80F5-4DCE9E142C6DQ40156397-199F3BAA-E855-4920-BA2D-2E79DD8131F7Q40444592-81F722B1-6D10-4410-BC65-C9FA7AB4559EQ40474665-10B3A08C-3774-4832-BD76-B4EA080EB220Q40478788-4DC342D0-DEC2-48CD-B93F-88B66CA73CE4Q40491223-30BCE663-0058-463D-AECF-08581FB40724
P2860
Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Brief report: reversible lymph ...... arthritis and dermatomyositis.
@en
Brief report: reversible lymph ...... arthritis and dermatomyositis.
@nl
type
label
Brief report: reversible lymph ...... arthritis and dermatomyositis.
@en
Brief report: reversible lymph ...... arthritis and dermatomyositis.
@nl
prefLabel
Brief report: reversible lymph ...... arthritis and dermatomyositis.
@en
Brief report: reversible lymph ...... arthritis and dermatomyositis.
@nl
P2093
P1476
Brief report: reversible lymph ...... arthritis and dermatomyositis.
@en
P2093
Del Zoppo GJ
Dorfman RF
Montgomery PG
Robbins BA
van de Rijn M
P304
P356
10.1056/NEJM199305063281806
P407
P577
1993-05-01T00:00:00Z